Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

rhoen-klinikum ag - RKAGY

RKAGY

Close Chg Chg %
6.51 -0.46 -7.07%

Closed Market

6.05

-0.46 (7.07%)

Volume: 200.00

Last Updated:

Mar 19, 2024, 2:48 PM EDT

Trade Now

Company Overview: rhoen-klinikum ag - RKAGY

RKAGY Key Data

Open

$6.05

 Day Range

6.05 - 6.05

52 Week Range

5.41 - 6.51

 Market Cap

$887.60M

Shares Outstanding

133.88M

 Public Float

N/A

Beta

0.12

 Rev. Per Employee

N/A

P/E Ratio

18.26

 EPS

$0.36

Yield

0.00%

 Dividend

$0.05

EX-DIVIDEND DATE

Jun 8, 2023

 SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

  

RKAGY Performance

No Data Available

RKAGY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Rhoen-klinikum Ag - RKAGY

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
1.74B 1.86B 1.71B 1.81B
Sales Growth
+6.70% +6.73% -7.81% +5.43%
Cost of Goods Sold (COGS) incl D&A
1.61B 1.69B 1.55B 1.66B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
79.15M 82.43M 72.03M 70.47M
Depreciation
74.36M 76.40M 66.77M 65.28M
Amortization of Intangibles
4.79M 6.03M 5.25M 5.19M
COGS Growth
+6.79% +4.56% -8.25% +7.34%
Gross Income
130.10M 173.74M 167.71M 147.30M
Gross Income Growth
+5.60% +33.54% -3.47% -12.17%
Gross Profit Margin
+7.46% +9.34% +9.78% +8.15%
2020 2021 2022 2023 5-year trend
SG&A Expense
151.01M 166.67M 146.57M 168.14M
Research & Development
- - - -
-
Other SG&A
151.01M 166.67M 146.57M 168.14M
SGA Growth
+6.69% +10.37% -12.06% +14.72%
Other Operating Expense
227.99K 236.40K 315.29K 216.22K
Unusual Expense
3.20M (1.71M) 12.25M (2.07M)
EBIT after Unusual Expense
(24.33M) 8.54M 8.57M (18.99M)
Non Operating Income/Expense
37.14M 27.47M 30.96M 74.56M
Non-Operating Interest Income
945.04K 582.72K 1.35M 11.37M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
8.43M 3.77M 4.28M 3.99M
Interest Expense Growth
+152.95% -55.22% +13.32% -6.74%
Gross Interest Expense
8.43M 3.77M 4.28M 3.99M
Interest Capitalized
- - - -
-
Pretax Income
4.38M 32.24M 35.26M 51.58M
Pretax Income Growth
-92.77% +635.47% +9.38% +46.27%
Pretax Margin
+0.25% +1.73% +2.06% +2.85%
Income Tax
1.67M (3.39M) 7.03M 8.18M
Income Tax - Current - Domestic
3.16M (2.80M) 6.29M 7.31M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(1.48M) (590.99K) 735.68K 864.89K
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.81M 35.73M 28.31M 43.43M
Minority Interest Expense
1.15M 2.28M 1.89M 1.57M
Net Income
1.65M 33.44M 26.43M 41.85M
Net Income Growth
-96.59% +1,921.89% -20.99% +58.38%
Net Margin Growth
+0.09% +1.80% +1.54% +2.31%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
1.65M 33.44M 26.43M 41.85M
Preferred Dividends
- - - -
-
Net Income Available to Common
1.65M 33.44M 26.43M 41.85M
EPS (Basic)
0.0124 0.2498 0.1974 0.3126
EPS (Basic) Growth
-96.57% +1,914.52% -20.98% +58.36%
Basic Shares Outstanding
133.88M 133.88M 133.88M 133.88M
EPS (Diluted)
0.0124 0.2498 0.1974 0.3126
EPS (Diluted) Growth
-96.57% +1,914.52% -20.98% +58.36%
Diluted Shares Outstanding
133.88M 133.88M 133.88M 133.88M
EBITDA
58.01M 89.26M 92.85M 49.41M
EBITDA Growth
+1.16% +53.86% +4.02% -46.78%
EBITDA Margin
+3.33% +4.80% +5.41% +2.73%

Rhoen-Klinikum Ag in the News